Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. The NIH’s foreign subaward crackdown is scrambling global collaborations, while China’s rapid ascent is reshaping drug development. Meanwhile, Wave Life Sciences sheds half its value on underwhelming obesity results. Also, breaking: I’m adopting a rogue…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. It’s an exciting week not only for biotech M&A, but also for my city (Chicago) as we gear up for our big game this Saturday. Going into JPM, it’s good to be a…
Genomic sequencing has helped Hong Kong identify the right treatments for cancer patients more quickly, according to an expert who also suggested that the city could be a “super-linker” between mainland China and the rest of the world in drug development. Aya El Helali, a clinician-scientist in medical oncology at the University of Hong Kong,…
Over the past decade, the Chinese government has been busy implementing regulatory initiatives in a bid to increase competitiveness on the global stage. Image credit: Love Employee via Shutterstock.com. China-based companies are responsible for 20% of drugs in development globally, reflecting the powerhouse role the country has embraced in the pharmaceutical industry. In a recent…
Northeastern University professor Raymond Booth first learned about propranolol, a drug developed to treat high blood pressure, in pharmacy school around 1978. In graduate school, he noticed classmates using the drug not for heart conditions but to manage situational anxiety, especially during exams. Curious, he asked a friend how she knew to take it. She…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. The news coming out of D.C. never stops. We get into all of it below. Trump reportedly discussing crackdown on Chinese drugs The Trump administration is considering implementing severe restrictions on drugs from…
By Sneha S K and Puyaan Singh (Reuters) -Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in the near future. Within the next three to five years, using AI and cutting back on animal…